Genetic inference of immune responsiveness of melanoma cancer patients to TIL therapy

Genetic inference of immune responsiveness of melanoma cancer patients to TIL therapy

Bibliographic Details
Main Authors:	Sommariva, Michele, Cheung, Foo, Chen, Jinguo, Shi, Rongye, Zhang, Ling, Morgan, Richard, Bedognetti, Davide, De Giorgi, Valeria, Ascierto, Maria L, Rosenberg, Steven A, Marincola, Francesco M, Wang, Ena
Format:	Online
Language:	English
Published:	BioMed Central 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991192/

Similar Items

NGS technology applied to melanoma cell lines
by: De Giorgi, Valeria, et al.
Published: (2013)

Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome
by: Bedognetti, Davide, et al.
Published: (2014)

The immune‐related role of BRAF in melanoma
by: Tomei, Sara, et al.
Published: (2014)

The immune-related role of BRAF in melanoma
by: Tomei, Sara, et al.
Published: (2015)

Genomic scale analysis of NK cells impact on response to IFN-α
by: Ascierto, Maria L, et al.
Published: (2013)

Tissue Biomarkers in Melanoma Patients Treated with TIL
by: Knol, Anne-Chantal, et al.
Published: (2012)

The stable traits of melanoma genetics: an alternate approach to target discovery
by: Spivey, Tara L, et al.
Published: (2012)

A genetic inference on cancer immune responsiveness
by: Wang, Ena, et al.
Published: (2012)

Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C Virus
by: Ascierto, Maria Libera, et al.
Published: (2015)

Association between HRAS rs12628 and rs112587690 polymorphisms with the risk of melanoma in the North American population
by: Tomei, Sara, et al.
Published: (2012)

IRF5 gene polymorphisms in melanoma
by: Uccellini, Lorenzo, et al.
Published: (2012)

What’s new in melanoma? Combination!
by: Ascierto, Paolo A, et al.
Published: (2015)

PBMC fixation and processing for Chromium single-cell RNA sequencing
by: Jinguo Chen, et al.
Published: (2018-07-01)

Adoptive TIL Transfer in the Adjuvant Setting for Melanoma: Long-Term Patient Survival
by: Khammari, Amir, et al.
Published: (2014)

Toward the identification of genetic determinants of breast cancer immune responsiveness
by: Simeone, Ines, et al.
Published: (2015)

CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2
by: Bedognetti, D, et al.
Published: (2013)

2015: The Year of Anti-PD-1/PD-L1s Against Melanoma and Beyond
by: Ascierto, Paolo A., et al.
Published: (2015)

Erhvervsskolelærere til eksamen
by: Henriette Duch
Published: (2016-11-01)

Melanoma: From Research to Treatment
by: Ascierto, Paolo A., et al.
Published: (2011)

Spørgeskemaer som redskab til undervisningsevaluering
by: Peter Nielsen, et al.
Published: (2016-03-01)

TIlE FORTS OF THE LIESBEECK FRONTIER
by: Ian Van der Waag
Published: (2012-02-01)

Corrigendum: Effects of Systemically Administered Hydrocortisone on the Human Immunome
by: Olnes, Matthew J., et al.
Published: (2016)

Effects of Systemically Administered Hydrocortisone on the Human Immunome
by: Olnes, Matthew J., et al.
Published: (2016)

TIL therapy broadens the tumor-reactive CD8+ T cell compartment in melanoma patients
by: Kvistborg, Pia, et al.
Published: (2012)

Interferon-γ and Tumor Necrosis Factor-α Polarize Bone Marrow Stromal Cells Uniformly to a Th1 Phenotype
by: Jin, Ping, et al.
Published: (2016)

Clinical scale zinc finger nuclease (ZFN)-driven gene-editing of PD-1 in tumor infiltrating lymphocytes (TIL) for the potential treatment of metastatic melanoma
by: Beane, Joal D, et al.
Published: (2014)

Intratumoral checkpoint subversion as a strategy for minimizing adverse effects: Harvesting the power of TILs without harvesting TILs
by: Alabanza, Leah, et al.
Published: (2014)

Walk 'til You Run Out of Water
by: Phillips, Perdita
Published: (2012)

Mottatte bøker til Edda 3/2018
Published: (2018-01-01)

Evaluering som redskab til forandring af folkeskolen
by: Finn Møller
Published: (2016-02-01)

ørkvalitetsrapporten til et udviklings- og videndelingsværktøj
by: Lene Tetzlaff-Petersen, et al.
Published: (2016-03-01)

Adoptive TIL in HPV-negative oral scca
by: Leidner, Rom, et al.
Published: (2015)

An immunologic portrait of cancer
by: Ascierto, Maria Libera, et al.
Published: (2011)

Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis
by: Spivey, Tara L, et al.
Published: (2011)

IRF-1 responsiveness to immune cytokines predicts different cancer phenotypes
by: Murtas, Daniela, et al.
Published: (2013)

Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions
Published: (1996)

A phase I trial of repeated tumour-infiltrating lymphocyte (TIL) infusion in metastatic melanoma.
by: Ravaud, A., et al.
Published: (1995)

Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy
by: Kelderman, Sander, et al.
Published: (2013)

Genetically engineered lymphocytes in metastatic melanoma: TIL 1383I TCR transduced T-cells are detectable after infusion
by: Regan, Courtney, et al.
Published: (2013)

Identification of predictive biomarker signatures in melanoma tumors associated with response to tumor-infiltrating lymphocyte (TIL) therapy
by: Chen, Jie Qing, et al.
Published: (2013)